Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin- induced preterm parturition in mice

Journal of the Society for Gynecologic Investigation

Volumn 4, Issue 1, 1997, Pages 22-26

  Fidel Jr , Paul L ^a   Romero, Roberto ^b   Cutright, Jessica ^b   Wolf, Norbert ^b   Gomez, Ricardo ^b   Araneda, Heriberto ^b   Ramirez, Marcelo ^b   Yoon, Bo Hyun ^b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b NONE

Author keywords

endotoxin; interleukin I receptor antagonist; murine model; Preterm parturition; soluble tumor necrosis factor receptor Fc fusion protein

Indexed keywords

HYBRID PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CHILDBIRTH; DELIVERY; DRUG EFFECT; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL;

ANIMALS; FEMALE; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MICE; MICE, INBRED C3H; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RECEPTORS, INTERLEUKIN; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS;

EID: 0031052455     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(96)00060-3     Document Type: Article

References (43)

1. 1. Benedetti TJ, Valle R, Ledger WJ. Antepartum pneumonia in pregnancy. Am J Obstet Gynecol 1976;144:413-7.
2. 2. Cunningham FG, Morris GB, Mikal A. Acute pyelonephritis of pregnancy: A clinical review. Obstet Gynecol 1973;42:112-7.
3. 3. Diddle AW, Stephens RL. Typhoid fever in pregnancy: Probable intrauterine transmission of the disease. Am J Obstet Gynecol 1938;38:300-12.
4. 4. Fan Y-D, Pastorek JG, Miller JM, Mulvey J. Acute pyelonephritis in pregnancy. Am J Perinatol 1987;4:324-6.
5. 5. Oxorn H. The changing aspects of pneumonia complicating pregnancy. Am J Obstet Gynecol 1955;70:1057-63.
6. 6. Gilles HM, Lawson JB, Sibelas M, Voller A, Allan N. Malaria, anaemia and pregnancy. Ann Trop Med Pharmacol 1969;63: 245-63.
7. 7. Herd N, Jordan T. An investigation of malaria during pregnancy in Zimbabwe. C Afr J Med 1981;27:62-8.
8. 8. Kass E. Maternal urinary tract infection. NY State J Med 1962; 1:2822-6.
9. 9. Madinger NE, Greenspoon JS, Ellrodt AG. Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome? Am J Obstet Gynecol 1989;161:657-62.
10. 10. McLane CM. Pyelitis of pregnancy: A five-year study. Am J Obstet Gynecol 1939;38:117-23.
11. 11. Stevenson CS, Glasko AJ, Gillespie EC. Treatment of typhoid in pregnancy with chloramphenicol (chloromycetin). JAMA 1951; 146:1190.
12. 12. Wing ES, Troppoli DV. The intrauterine transmission of typhoid. JAMA 1930;95:405.
13. 13. Gomez R, Ghezzi F, Romero R, et al. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 1995;22: 281-342.
14. 14. Sereno JA, Poseiro JJ, Sica-Blanco Y, Pose SV. Stimulatory effects of chills on the contractility of the pregnant human uterus. International Congress of Physicians in Science, Buenos Aires, Argentina, August 9-15, 1959.
15. 15. Takeda Y, Tsuchiya I. Studies on the pathological changes caused by the injection of the Shwartzman filtrate and the endotoxin into pregnant rabbits. Jpn J Exp Med 1953;21:9-16.
16. 16. Takeda Y, Tsuchiya I. Studies on the pathological changes caused by the injection of the Shwartzman filtrate and the endotoxin into pregnant animals. II. On the relationship of the constituents of the endotoxin and the abortion-producing factor. Jpn J Exp Med 1953;23:105-10.
17. 17. Rieder RF, Thomas L. Studies on the mechanisms involved in the production of abortion by endotoxin. J Immunol 1960;84: 189-93.
18. 18. Fidel PL Jr, Wolf N, Ramirez M, et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994;170:1467-75.
19. 19. Eisenberg SP, Evans RJ, Arend WP, et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990;343:341-6.
20. 20. Carter DB, Deible MR Jr, Dunn CJ, et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990;344:633-8.
21. 21. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52.
22. 22. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990;348:550-2.
23. 23. McIntyre KW, Stepan GJ, Kolinsky KD, et al. Inhibition of interleukin-1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 1991; 173:931-9.
24. 24. McCarthy PL Jr, Abhyankar S, Neben S, et al. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood 1991;78:1915-8.
25. 25. Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA. A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J 1991;338-43.
26. 26. Fisher E, Marano MA, Van Zee KJ, et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 1992;89:1551-7.
27. 27. Romero R, Tartakovsky B. The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice. Am J Obstet Gynecol 1992;167:1041-5.
28. 28. Fidel PL Jr, Romero R, Ramirez M, et al. Interleukin-1 receptor antagonist IL-1ra production by human amnion, chorion, and decidua. Am J Reprod Immunol 1994;32:1-7.
29. 29. Mohler KM, Torrance DS, Smith CA, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonist. J Immunol 1993;151:1548-61.
30. 30. Romero R, Brody DT, Oyarzun E, et al. Infection and labor. III. Interleukin-1: A signal for the onset of parturition. Am J Obstet Gynecol 1989;160:1117-23.
31. 31. Romero R, Manogue KR, Mitchell MD, et al. Infection and labor. IV. Cachetic-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989;161:3336-41.
32. 32. Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin-6 in preterm labor. Association with infection. J Clin Invest 1990;85:1392-400.
33. 33. Romero R, Ceska M, Alvila C, Mazor M, Behnke E, Lindley I. Neutrophil attractant/activating peptide-1/interleukm-8 in term and preterm parturition. Am J Obstet Gynecol 1991;165:813-20.
34. 34. Romero R, Mazor M, Brandt F, et al. Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol 1992;27:117-23.
35. 35. Romero R, Gomez R, Galasso M, et al. The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: The effect of gestational age, fetal gender, and intrauterine infection. Am J Obstet Gynecol 1994;171:912-19.
36. 36. Paris MM, Friedland IR, Ehrett S, et al. Effect of interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor in animal models of infection. J Infect Dis 1995;171:161-9.
37. 37. Suffredini AF, Reda D, Banks SM, et al. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol 1995; 155:5038-45.
38. 38. Ralph P, Nakoinz I, Sampson-Johannes A, et al. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992;148:808-14.
39. 39. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
40. 40. Tada T, Ohzeki S, Utsumi K, et al. Transforming growth factor-beta-induced inhibition of T cell function: Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in tumor-bearing state. J Immunol 1991;146:1077-82.
41. 41. Ahuja SS, Paligianni F, Yamada H, Balow JE, Boumpas DT. Effect of transforming growth factor-beta on early and late activation events in human T cells. J Immunol 1993;150:3109-18.
42. 42. Inge TH, McCoy KM, Susskind BM, Barrett SK, Zhao G, Bear HD. Immunomodulatory effects of transforming growth factor-beta-on T lymphocytes: Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes. J Immunol 1992; 148:3847-56.
43. 43. Bry K, Hallman M. Transforming growth factor-beta 2 prevents preterm delivery induced by interleukin-1 alpha and tumor necrosis factor-alpha in the rabbit. Am J Obstet Gynecol 1993;168: 1318-22.